Polly Leontaridis-Kalogera – Managing Director, Italfarmaco Greece
Equipped with a strong business acumen, Italfarmaco (ITF) Hellas’ Managing Director, Polly Leontaridis-Kalogera…
Address: V.le Fulvio Testi, 330, 20126 Milano,Italy
Tel: 02 64431
Web: http://www.italfarmaco.com/
Italfarmaco operates in both the pharmaceutical and the fine chemical industries and was founded in Milan in 1938.
The Italfarmaco Group now markets ethical products in Italy, Spain, Portugal and Greece, where it employs a workforce of over 1400 and has a total turnover exceeding 300 million euros.
The groups owns a plant in Milan, and a second in Madrid.
The Italfarmaco Group is particularly active in the field of research, mainly oriented towards the cardiovascular area and diseases associated with alterations of the immunological system.
In addition to its pharmaceutical activities in the field of ethical drugs, Italfarmaco also markets generic drugs through the company Lifepharma.
This business is mainly aimed at foreign markets, on some of which Lifepharma has its own offices and sales networks, as in the case of Russia.
In addition to research, production and marketing of drugs, the Italfarmaco Group manufactures active ingredients for the pharmaceutical industry through its subsidiary ‘Chemi S.p.A.’
Chemi S.p.A. sells some 90% of its products on foreign markets (USA, Japan, EU, etc.), on which it collaborates with many international pharmaceutical companies.
Its therapeuticals areas are mainly cardiovascular, immuno-oncological, gynaecological, dermatological, orthopaedic and neurological areas.
Equipped with a strong business acumen, Italfarmaco (ITF) Hellas’ Managing Director, Polly Leontaridis-Kalogera…
Italfarmaco counts amongst the few players who really sustained the growth of the Italian pharmaceutical industry…
The latest from Italian pharma, including the government’s decision to make COVID-19 vaccines mandatory for all…
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
In July 2020, Italy became the first country in the world to mandate pharma companies to disclose data surrounding…
Below we present recent news from Italy’s biopharma industry, including the recent acquisition of Stemline…
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US…
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based…
Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community,…
The division of neuroscience at the San Raffaele Scientific Institute is one of the best worldwide performers in…
Professor Angelo Corti, Director of the Experimental Oncology division of the SRSI, discusses approaches to…
Dr. Paola Pozzi, the head of the Office of Biotechnology Transfer at the San Raffaele Scientific Institute,…
Italy’s traditional family-owned pharmaceutical companies are one of its greatest strengths; but these companies…